Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
Author:
Open Access
- 1 January 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 144 (1) , 307-312
Abstract
One-week-old mice were protected against a uniformly lethal herpes simplex virus (HSV) infection by IL-2 alone, but especially by the addition of human mononuclear cells (MC) plus IL-2. The dose response of IL-2 was biphasic. The addition of MC from cord blood did not enhance IL-2-mediated survival. Because the effect of IL-2 alone, or IL-2 plus MC, was ablated by anti-IFN-gamma and human neonates have an IFN-gamma production defect, the protective effect of MC plus human IFN-gamma (HuIFN-gamma) was tested. MC from adults cultured for 5 days in HuIFN-gamma afforded protection. At least 1 x 10(6) HuIFN-gamma-treated MC were required with increasing survival to 1 x 10(7) MC. The effector cell activity was ablated by adherence, silica, l-leucine methyl ester treatment or treatment with Leu-M3 plus C (all macrophage markers), and OKT4 plus C treatment (CD4 marker). Use of Leu-11, Leu-7, OKT3, or OKT8 plus C did not inhibit protection and excluded NK or T cell participation. In addition to survival, the ability to produce anti-HSV antibody was reconstituted. For the first time protection was afforded by human cord blood MC after treatment with HuIFN in vitro. We have identified an IFN-gamma-driven protection system against murine neonatal HSV infection mediated by human adult- or cord blood-derived CD4-positive macrophages. Protection is associated with enhanced effector cell function and reconstitution of the neonatal antibody production defect.Keywords
This publication has 20 references indexed in Scilit:
- Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.The Journal of Immunology, 1983
- Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes.The Journal of Immunology, 1983
- Stimulation of Human Natural Killer Cytotoxicity and Protection of Mice from Infection Due to Herpes Simplex Virus by Recombinant Human Leukocyte InterferonThe Journal of Infectious Diseases, 1983
- Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.The Journal of Immunology, 1982
- Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.The Journal of Immunology, 1982
- Protection of neonatal mice against herpes simplex viral infection by human antibody and leukocytes from adult, but not neonatal humans.The Journal of Immunology, 1981
- Interferon induction of natural killer cytotoxicity in human neonatesThe Journal of Pediatrics, 1981
- Deficiency of immune interferon production by leukocytes of normal newbornsCellular Immunology, 1980
- Human Monocyte-Macrophage-Mediated Antibody-Dependent Cytotoxicity to Herpes Simplex Virus-Infected CellsThe Journal of Immunology, 1977
- Activity of Herpetic Virus in MiceThe Journal of Infectious Diseases, 1929